Skip to main content
. Author manuscript; available in PMC: 2023 Jan 20.
Published in final edited form as: J Natl Compr Canc Netw. 2022 Feb 22;20(4):343–350.e4. doi: 10.6004/jnccn.2021.7061

Figure 1:

Figure 1:

Unweighted Kaplan-Meier curves showing overall survival stratified by treatment with either definitive brachytherapy (BT) or external beam radiotherapy (EBRT) for (A) all men with unfavorable intermediate-risk (UIR) disease, (B) the subgroup of men treated without androgen-deprivation therapy (ADT), and (C) the subgroup of men treated with ADT. (D) Inverse probability of treatment weigting-adjusted Kaplan-Meier curves stratified by treatment with either BT or EBRT for all men with UIR disease.